Morgan Stanley Maintains Equal-Weight on Clorox, Lowers Price Target to $110

Benzinga Newsdesk www.benzinga.com Neutral 71.2%

Neg 0% Neu 71.2% Pos 0%

Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $136 to $110.